-
Potential Threat of Newly Identified ST20 Clone to Enzyme Inhibitor Combination Therapy: Findings from ESCMID Global 2024
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a significant challenge in nosocomial infections, with its resistance escalating, drawing global attention. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study by Professor Yunsong Yu’s team from the Zhejiang Provincial People’s Hospital presented the latest findings on the genomic epidemiology…
-
2024 CSCO Guidelines Conference | Prof. Dingwei Ye: Keeping Up with the Times, Serving Clinical Practice with a Prostate Cancer Guideline with Chinese Characteristics
Prostate cancer is the most common malignant tumor of the male urinary reproductive system. Compared to developed countries, China has a higher proportion of late-stage prostate cancer patients at diagnosis, resulting in poorer prognosis. In recent years, there have been rapid advancements in prostate cancer research. Therefore, developing diagnosis and treatment guidelines tailored to China…
-
2024 South-North Forum | Prof. Hong Hu: Should CDK4/6 Inhibitors Be Used for N0 Patients with Limited High-Risk Factors?
For hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer patients with no lymph node involvement (N0) and limited high-risk factors, the consensus has been that their risk of recurrence is low, and adjuvant endocrine therapy alone is sufficient. However, with the release of studies like NATALEE, it has become apparent that intensifying treatment…
-
2024 CSCO Guidelines Conference | Prof. Jun Ma: The Chinese Society of Clinical Oncology (CSCO) Guidelines for Malignant Hematologic Diseases Promote Standardized Diagnosis and Treatment in China and Improve Clinical Outcomes
The “2024 Chinese Society of Clinical Oncology (CSCO) Guidelines for Malignant Hematologic Diseases” are set to be released, updating the latest treatment strategies and methods for malignant hematologic diseases. This is a significant event for the hematology field in China. “Oncology Frontier” conducted an exclusive interview with Professor Jun Ma from the Harbin Institute of…
-
2024 EBMT Review | Professor Jun Ma:CARTITUDE-4 Study—Comparison of Efficacy between Cilta-cel and Standard Treatments in Patients with Relapsed or Refractory Multiple Myeloma
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…
-
2024 EBMT Review | Professor Jun Ma:Development Study of Disease-Specific Composite Endpoints for CAR-T Cell Therapy in Large B-cell Lymphoma and Multiple Myeloma
From April 14 to 17, 2024, the 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was grandly held in Glasgow, UK, a city renowned for its historical significance. This year marks the 50th anniversary of EBMT, and the event gathered leading figures in the field of hematopoietic stem cell transplantation and over…
-
Guidelines Consensus | Key Insights from the “Expert Consensus on Prevention and Treatment of Chronic Hepatitis B in Children” in China
With the widespread implementation of standard immunization programs and mother-to-child transmission prevention measures, the incidence of new HBV infections among children in China has significantly declined. However, due to the large base of hepatitis B patients and regional developmental disparities, the number of new and existing cases of HBV infections among children remains high.
-
Insights from a Study by Professor Yunsong Yu’s Team at ESCMID Global 2024
Carbapenem-resistant Enterobacteriaceae (CRE) has emerged as a significant global public health threat. In recent years, there has been increasing attention on ertapenem monotherapy-resistant CRE strains, making it a hot topic in the field. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study (abstract number: P1469) by Professor Yunsong…
Connecting Medical Expertise through Media